Delays to the 2nd dose of COVID Vaccine can be harmful in cancer patients.

The Pfizer vaccine was tested in clinical trials with two doses given at 3 to 4 week interval.

But during Vaccination of the General population, the UK has taken a pragmatic view and delayed the 2nd Vaccine dose by up to 12 weeks.

A recent study suggests that this delay in administering 2nd Vaccine dose might put cancer patients at risk.

References

1. Guardian. Delaying second Pfizer dose leaves cancer patients at risk, say researchers
Covid vaccination policy review urged after study finds 12-week gap leaves patients vulnerable
.
PA Media
Thu 11 Mar 2021 16.40 GMT

Disclaimer: Please note- This blog is NOT medical advice. This blog is NOT a expert medical opinion on various topics. This blog is purely for information only and do check the the sources where cited. Please DO consult your own doctor to discuss concerns and options relevant to you.

The views expressed in this blog represent the author’s views held at the time of drafting the blog and may change overtime, particularly when new evidence comes to light. The blog is not previewed, commissioned or otherwise endorsed by any organisation the author is associated with. The authors views are not in way intended to be a substitute for professional advice.